Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease

Diabetes

Volumn 46, Issue 9, 1997, Pages 1491-1496

  Mäki, Maija ^a   Nuutila, Pirjo ^a   Laine, Hanna ^a   Voipio Pulkki, Liisa Maria ^a   Haaparanta, Merja ^b   Solin, Olof ^a   Knuuti, Juhani M ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU PET CENTRE   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; NITRATE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; GLUCOSE TRANSPORT; HEART MUSCLE METABOLISM; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030768242     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.9.1491     Document Type: Article

References (47)

1. DeFronzo RA, Simonson D, Ferrannini E: Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin dependent) and type 1 (insulin-dependent) diabetes. Diabetologia 23:313-319, 1982
2. Bogardus C, Lillioja S, Howard BV, Reaven GM, Mott D: Relationship between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238-1246, 1984
3. Kolterman OG, Insel J, Saekow M, Olefsky JM: Mechanisms of insulin resistance in human obesity. J Clin Invest 65:1272-1284, 1980
4. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
5. Reaven GM: Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. Am Heart J 121:1283-1288, 1991
6. Spallarossa P, Cordera R, Andraghetti G, Bertero G, Brunelli C, Caponnetto S: Association between plasma insulin and angiographically documented significant coronary artery disease. Am J Cardiol 74:177-179, 1994
7. Wingard D, Barrett-Connor E, Ferrara A: Is insulin really a heart disease risk factor? Diabetes Care 18:1299-1304, 1995
8. van Hoeven KH, Factor SM: Diabetic heart disease. I. The clinical and pathological spectrum. Clin Cardiol 12:600-604, 1989
9. Schelbert H, Buxton D: Insights into coronary artery disease gained from metabolic imaging. Circulation 78:496-505, 1988
10. Schaffer S, Seyed-Mozaffard M, Cutclift C, Wilson G: Postreceptor myocardial metabolic defect in a rat model of non-insulin-dependent diabetes mellitus. Diabetes 35:593-597, 1986
11. Voipio-Pulkki L-M, Nuutila P, Knuuti MJ, Ruotsalainen U, Haaparanta M, Teräs M, Wegelius U, Koivisto V: Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined with positron emission tomography. J Nucl Med 34:2064-2067, 1993
12. Ohtake T, Yokoyama I, Watanabe T, Momose T, Serezawa T, Nishikawa J, Sasaki Y: Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 36:456-463, 1995
13. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MC, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M: The 14-C-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rats. J Neurochem 28:897-916, 1977
14. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE: Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6:371-388, 1979
15. Patlak CS, Blasberg RG: Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 5:584-590, 1985
16. 18F-deoxyglucose. J Nucl Med 30:359-366, 1989
17. Nuutila P, Knuuti J, Ruotsalainen U, Koivisto V, Eronen E, Teräs M, Bergman J, Haaparanta M, Voipio-Pulkki L-M, Viikari J, Rönnemaa T, Wegelius U, Yki-Järvinen H: Insulin resistance is localized to skeletal but not heart muscle in type I diabetes. Am J Physiol 264 (Endocrinol Metab 27):E756-E762, 1993
18. Nuutila P, Mäki M, Laine H, Knuuti J, Ruotsalainen U, Luotolahti M, Haaparanta M, Solin O, Jula A, Voipio-Pulkki L-M, Yki-Järvinen H: Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest 96:1003-1009, 1995
19. vom Dahl J, Herman W, Hicks R, Ortiz-Alonso F, Lee K, Allman K, Wolfe E, Kalff V, Schwaiger M: Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation 88:395-404, 1993
20. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
21. Knuuti MJ, Nuutila P, Ruotsalainen U, Saraste M, Härkönen R, Ahonen A, Teräs M, Haaparanta M, Wegelius U, Haapanen A, Hartiala J, Voipio-Pulkki L-M: Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 33:1255-1262, 1992
22. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235-238, 1986
23. 18F from water targets, specific radioactivity and anionic contaminants. Int Radiat Isot 39:1065-1071, 1988
24. Ratib O, Phelps ME, Huang S-C, Henze E, Selin CE, Schelbert HR: Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 23:577-586, 1982
25. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman N, Tajik A: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2:358-367, 1989
26. Kadish AH, Little RL, Sternberg JC: A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116-131, 1968
27. Kuzuya H, Blix BM, Horwitz DL, Steiner DF, Rubenstein A: Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:22-29, 1977
28. Miles J, Glasscock R, Aikens J, Gerich J, Haymond M: A microfluorometric method for the determination of free fatty acids in plasma J Lipid Res 24:96-99, 1983
29. Thomassen A, Bagger JP, Nielsen TT, Henningsen P: Altered global myocardial substrate preference at rest and during pacing in coronary artery disease with stable angina pectoris. Am J Cardiol 62:686-693, 1988
30. Uren NG, Marraccini P, Gistri R, DeSilva R, Camici PG: Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol 22:650-658, 1993
31. Thomassen A, Nielsen TT, Bagger JP, Henningsen P: Cardiac metabolic and hemodynamic effects of insulin in patients with coronary artery disease. Diabetes 38:1175-1180, 1989
32. Patemostro G, Camici P, Lammerstma A, Marinho N, Baliga R, Kooner J, Radda G, Ferrannini E: Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. J Clin Invest 98:2094-2099, 1996
33. Vuorinen-Markkola H, Yki-Järvinen H, Taskinen M-R: Lowering of triglycerides by gemfibrozil affects neither the glycoregulatory nor antilipolytic effect of insulin in type 2 (non-insulin dependent diabetic patients). Diabetologia 36:161-169, 1993
34. Rizza R, Mandarino L, Gerich J: Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes 30:990-995, 1981
35. Del Prato S, Bonadonna R, Bonora E, Gulli G, Solini A, Shank M, DeFronzo R: Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest 91:484-494, 1993
36. Manchester J, Kong X, Nerbonne J, Lowry OH, Lawrence JC: Glucose transport and phosphorylation in single cardiac myocytes: rate limiting steps in glucose metabolism. Am J Physiol 266 (Endocrinol Metab 29):E326-E333, 1994
37. Opie LH: Fuels: carbohydrates and lipids. In The Heart, Physiology, and Metabolism. New York, Raven Press, 1991, p. 208-246
38. Neely JR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 36:413-459, 1974
39. Ferrannini E, Santori D, Bonadonna R, Natali A, Parodi O, Camici PG: Metabolic and hemodynamic effects of insulin on human heart Am J Physiol 264 (Endocrinol Metab 27):E308-E315, 1993
40. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785-789, 1963
41. Randle PJ, Newsholme EA, Garland PB: Regulation of glucose uptake by muscle: effects of fatty acids, ketone bodies and pyruvate, and alloxan, diabetes and starvation, on the uptake and metabolism fate of glucose in rat heart and diaphragm muscles. Biochem J 93:652-665, 1964
42. Knuuti MJ, Mäki M, Yki-Järvinen H, Voipio-Pulkki L-M, Härkönen R, Haaparanta M, Nuutila P: The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol 27:1359-1367, 1995
43. Yki-Järvinen H: Action of insulin on glucose metabolism in vivo. In Clinical Endocrinology and Metabolism: Insulin Resistance and Disease. Vol. 7. Ferrannini E, Ed. London, Baillière Tindall, 1993, p. 903-927
44. Krivokapich J, Huang SC, Phelps ME, Barrio JR, Watanabe CR, Selin CE, Shine KI: Estimation of rabbit myocardial metabolic rate for glucose using fluorodeoxyglucose. Am J Physiol 243:H884-H895, 1982
45. Krivokapich J, Huang SC, Selin CE, Phelps M: Fluorodeoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart Am J Physiol 252:H777-H787, 1987
46. 18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation 91:2435-2444, 1995
47. Mäki M, Luotolahti M, Nuutila P, Iida H, Voipio-Pulkki L-M, Ruotsalainen U, Haaparanta M, Solin O, Hartiala J, Härkönen R, Knuuti J: Glucose uptake in the chronically dysfunctioning but viable myocardium. Circulation 93:1658-1666, 1996